Lithuania on Thursday quit an international convention banning cluster bombs, citing security concerns over neighbouring Russia in a move that has drawn criticism from human rights groups.

Lithuania formally withdrew on March 6 from the Convention on Cluster Munitions, an international treaty that bans the production and distribution of this controversial weaponry. The Lithuanian parliament voted to exit the treaty last July,

Homann Holzwerkstoffe GmbH: Permits issued for the start of operations at the new plant in Lithuania

Lithuania has invested EUR 20 million in Ukraine's defense industry and aims to establish joint weapons production with Ukraine. — Ukrinform.

WhiteBIT, Europe’s largest cryptocurrency exchange by traffic, has partnered with Bequant, a leading provider of institutional crypto trading solutions. This collaboration is keen to create a comprehensive ecosystem tailored for institutional traders, offering modern trading tools and compliance-driven infrastructure.

Exergio offers a use case: integrating humanoid robots into property and energy management for commercial buildings.

One of Taiwan’s most significant foreign policy achievements since the COVID-19 pandemic was the expansion of its unofficial diplomatic cooperation with

Today, the owner of Meraki Business Home in Vilnius, BH Meraki UAB, an SPV of Baltic Horizon Fund, signed a real estate sale and purchase agreement with Groa Real Estate Opportunity Fund UAB, a fund managed by Groa Capital to sell Meraki Business Home in Vilnius, Lithuania.

Hotels ranked on industry awards, guest reviews and hotel class ratings Unbiased content created by U.S. News editors Photo tours of select hotels by local experts Navigate forward to interact with the calendar and select a date.

With the handing of awards in four different categories, the LTOK honoured those who embody the values of respect, solidarity and integrity this

Micreos Pharmaceuticals AG (”Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease aggravation,